| 2025-09-23 |
股东大会：
将于2025-10-28召开股东大会
会议内容 ▼▲
- 1.That pursuant to (and subject to approval of) the Scheme between the Company and the holders of Scheme Shares in the form of the print contained in the Scheme Document, which has been produced to this meeting and for the purposes of identification signed by the chairman of this meeting, or in such other form and on such terms and conditions as may be approved or imposed by the Grand Court of the Cayman Islands, on the Effective Date, the issued share capital of the Company shall be reduced by cancelling and extinguishing the Scheme Shares (including Scheme Shares underlying the ADSs).
2.That:(A)subject to and contemporaneously with the cancellation and extinguishment of the Scheme Shares referred to in special resolution (1), the issued share capital of the Company shall be restored to the amount prior to the cancellation of the Scheme Shares by applying the reserve created as a result of the aforesaid cancellation of the Scheme Shares to pay up in full at par such number of new Shares as is equal to the number of Scheme Shares cancelled as a result of the Scheme, credited as fully paid, for issuance to the Offeror;
(B)any one of the Directors be and is hereby authorized to do all such acts and things considered by him/her to be necessary or desirable in connection with the implementation of the Scheme, including (without limitation) the giving of consent to any modification of or addition to, the Scheme or any reduction of capital, which the Grand Court of the Cayman Islands may see fit to impose;
(C)any one of the Directors be and is hereby authorized to apply to Stock Exchange for the withdrawal of listing of the Shares and to apply to the NYSE for the delisting of the ADSs.
|
| 2025-09-23 |
详情>>
股本变动：
变动后总股本3899.94万股
|
| 2025-08-21 |
详情>>
业绩披露：
2025年中报每股收益-0.07元,归母净利润-7849.5万元,同比去年增长-156.47%
|
| 2025-08-21 |
财报披露：
美东时间 2025-08-21 盘前发布财报
|
| 2025-05-28 |
详情>>
业绩披露：
2025年一季报每股收益-0.04元,归母净利润-3836.2万元,同比去年增长63.23%
|
| 2025-04-24 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements and the reports of the directors of the Company (the “Directors”) and auditor for the year ended December 31, 2024.
2.(i)To re-elect Mr. Chen Dangyang as an executive Director.
(ii)To re-elect Ms. Xin Fu as a non-executive Director.
(iii)To re-elect Mr. Wenwei Dou as a non-executive Director.
(iv)To re-elect Dr. Yaolin Zhang as an independent non-executive Director.
(v)To re-elect Mr. Tianruo Pu as an independent non-executive Director.
(vi)To authorize the board (the “Board”) of Directors to fix the remuneration of the Directors.
3.To re-appoint PricewaterhouseCoopers as auditor and to authorize the Board to fix its remuneration.
|
| 2025-04-24 |
详情>>
业绩披露：
2024年年报每股收益-0.42元,归母净利润-4.6亿元,同比去年增长-26.73%
|
| 2025-04-24 |
详情>>
业绩披露：
2022年年报每股收益-0.8元,归母净利润-8.72亿元,同比去年增长31.94%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.10元,归母净利润1.10亿元,同比去年增长138.92%
|
| 2024-11-05 |
股东大会：
将于2024-12-18召开股东大会
会议内容 ▼▲
- 1.That the 2024 Provision of Products and Services Agreement, the transactions contemplated thereunder, and the proposed annual caps for the three years ending 31 December 2027, details of which are more particularly described in the Circular, be and are hereby approved, ratified and confirmed; and That any one executive Director be and is hereby authorized for and on behalf of the Company to execute, and where required, to affix the common seal of the Company to, any documents, instruments or agreements, and to do any acts and things deemed by him or her to be necessary, expedient or appropriate in order to give effect to and implement the transactions contemplated under the 2024 Provision of Products and Services Agreement (including the proposed annual caps thereunder for the three years ending 31 December 2027).
2.That the 2024 Services and Products Purchasing Agreement, the transactions contemplated thereunder, and the proposed annual caps for the three years ending 31 December 2027, details of which are more particularly described in the Circular, be and are hereby approved, ratified and confirmed; and That any one executive Director be and is hereby authorized for and on behalf of the Company to execute, and where required, to affix the common seal of the Company to, any documents, instruments or agreements, and to do any acts and things deemed by him or her to be necessary, expedient or appropriate in order to give effect to and implement the transactions contemplated under the 2024 Services and Products Purchasing Agreement (including the proposed annual caps thereunder for the three years ending 31 December 2027).
3.That the 2024 Financial Services Purchasing Agreement, the transactions contemplated thereunder, and the proposed annual caps for the three years ending 31 December 2027, details of which are more particularly described in the Circular, be and are hereby approved, ratified and confirmed; and That any one executive Director be and is hereby authorized for and on behalf of the Company to execute, and where required, to affix the common seal of the Company to, any documents, instruments or agreements, and to do any acts and things deemed by him or her to be necessary, expedient or appropriate in order to give effect to and implement the transactions contemplated under the 2024 Financial Services Purchasing Agreement (including the proposed annual caps thereunder for the three years ending 31 December 2027).
4.That the 2024 Property Leasing Agreement, the transactions contemplated thereunder, and the proposed annual caps for the three years ending 31 December 2027, details of which are more particularly described in the Circular, be and are hereby approved, ratified and confirmed; and That any one executive Director be and is hereby authorized for and on behalf of the Company to execute, and where required, to affix the common seal of the Company to, any documents, instruments or agreements, and to do any acts and things deemed by him or her to be necessary, expedient or appropriate in order to give effect to and implement the transactions contemplated under the 2024 Property Leasing Agreement (including the proposed annual caps thereunder for the three years ending 31 December 2027).
|
| 2024-08-16 |
详情>>
业绩披露：
2024年中报每股收益0.13元,归母净利润1.39亿元,同比去年增长172.99%
|
| 2024-07-18 |
详情>>
业绩披露：
2023年年报每股收益-0.33元,归母净利润-3.63亿元,同比去年增长58.42%
|
| 2024-05-21 |
详情>>
业绩披露：
2024年一季报每股收益-0.1元,归母净利润-1.04亿元,同比去年增长4.17%
|
| 2024-04-23 |
股东大会：
将于2024-05-28召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements and the reports of the directors of the Company (the “Directors”) and auditor for the year ended December 31, 2023.
2.To re-elect Mr. Chongfeng Shen as an executive Director.(ii)To re-elect Mr. Michael Guo as a non-executive Director.(iii)To re-elect Ms. Wenjun Wang as a non-executive Director.(iv)To re-elect Mr. Wing Kin Anthony Chow as an independent non-executive Director.(v)To re-elect Mr. Koon Wing Ernest Ip as an independent non-executive Director.(vi)To authorize the board (the “Board”) of Directors to fix the remuneration of the Directors.
3.To re-appoint PricewaterhouseCoopers as auditor and to authorize the Board to fix its remuneration.
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.26元,归母净利润-2.81亿元,同比去年增长59.51%
|
| 2023-08-16 |
详情>>
业绩披露：
2023年中报每股收益-0.17元,归母净利润-1.9亿元,同比去年增长66.13%
|
| 2023-04-24 |
股东大会：
将于2023-05-29召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements and the reports of the directors of the Company (the “Directors”) and auditor for the year ended December 31, 2022.
2.To re-elect Ms. Rong Chen as an executive Director.
To re-elect Ms. Sin Yin Tan as a non-executive Director.
To re-elect Ms. Xin Fu as a non-executive Director.
To re-elect Mr. Wenwei Dou as a non-executive Director.
To re-elect Mr. Min Zhu as a non-executive Director.
To re-elect Dr. Yaolin Zhang as an independent non-executive Director.
To re-elect Mr. Tianruo Pu as an independent non-executive Director.
To authorize the board (the “Board”) of Directors to fix the remuneration of the Directors.
3.To re-appoint PricewaterhouseCoopers as auditor and to authorize the Board to fix its remuneration.
4.To consider and if thought fit, pass with or without amendments, the following resolution as an ordinary resolution:“THAT:
(a)subject to the following provisions of this resolution, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to allot, issue and deal with additional shares of US$0.00001 each in the share capital of the Company (the “Shares”) or securities convertible into Shares, or options, warrants or similar rights to subscribe for Shares or convertible securities of our Company (other than issuance of options, warrants or similar rights to subscribe for additional Shares or securities convertible into Shares for cash consideration), and to make or grant offers, agreements and options (including warrants, bonds and debentures conferring any rights to subscribe for or otherwise receive Shares) which would or might require the exercise of such powers, subject to and in accordance with all applicable laws, be and is hereby generally and unconditionally approved;
(b)the approval in paragraph (a) of this resolution shall authorize the Directors during the Relevant Period to make or grant offers, agreements and options (including warrants, bonds and debentures conferring any rights to subscribe for or otherwise receive Shares) which would or might require the exercise of such powers after the end of the Relevant Period;
(c)the aggregate number of shares allotted or agreed conditionally or unconditionally to be allotted (whether pursuant to an option or otherwise) and issued by the Directors pursuant to the approval in paragraph (a) of this resolution, otherwise than pursuant to (i) a Rights Issue (as hereinafter defined); (ii) the grant or exercise of any options or the vesting of share units granted to be granted under any option scheme, restricted shares scheme or similar arrangements for the time being adopted by our Company in general meeting providing for the right to subscribe for or acquire Shares, including under the Stock Incentive Plan (as amended from time to time); (iii) any scrip dividend or similar arrangement providing for the allotment and issue of shares of our Company in lieu of the whole or part of a dividend on shares of our Company in accordance with the articles of association of our Company; and; (iv) a specific authority granted by our Shareholders in general meeting in an amount not exceeding 20% of the total number of issued shares of our Company as at the date of the passing of this resolution; and for the purposes of this paragraph;
(d)for the purpose of this resolution, “Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(i)the conclusion of the next annual general meeting of the Company;(ii)the expiration of the period within which the next annual general meeting of the Company is required by the articles of association of the Company or any applicable law of the Cayman Islands to be held;(iii)the date on which such mandate is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.“Rights Issue” means an offer of shares of our Company, or an offer or issue of warrants, options or other securities giving rights to subscribe for shares of our Company, open for a period fixed by the Directors to holders of shares of our Company whose names appear on the register of members of our Company on a fixed record date in proportion to their then holdings of such shares of our Company (subject to such exclusions or other arrangements as the directors” may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of any recognized regulatory body or any stock exchange in, any territory applicable to our Company.”
5.To consider and if thought fit, pass with or without amendments, the following resolution as an ordinary resolution:“THAT:
(a)subject to paragraph (c) of this resolution, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to repurchase the Shares on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) or any other stock exchange on which Shares may be listed and recognized by the Securities and Futures Commission of Hong Kong and the Stock Exchange for this purpose, subject to and in accordance with all applicable laws and the requirements of the Rules Governing the Listing of Securities on the Stock Exchange or those of any other recognized stock exchange as amended from time to time, be and is hereby generally and unconditionally approved;
(b)the approval in paragraph (a) of this resolution above shall be in addition to any other authorization given to the Directors and shall authorize the Directors on behalf of the Company during the Relevant Period (as hereinafter defined) to procure the Company to repurchase its shares at a price determined by the Directors;
(c)the aggregate number of shares of the Company in issue, which may be repurchased by the Company pursuant to the approval in paragraph (a) of this resolution shall not exceed 10% of the aggregate number of shares of the Company in issue as at the date of the passing of this resolution, and the said approval shall be limited accordingly;
(d)for the purpose of this resolution, “Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(i)the conclusion of the next annual general meeting of the Company;(ii)the expiration of the period within which the next annual general meeting of the Company is required by the articles of association of the Company or any applicable law of the Cayman Islands to be held;(iii)the date on which such mandate is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.”
6.To consider and if thought fit, pass with or without amendments, the following resolution as an ordinary resolution:“THAT conditional upon resolutions numbered 4 and 5 above being passed, the unconditional general mandate granted to the Directors to allot, issue and deal with additional shares and to make or grant offers, agreements, and options which might require the exercise of such powers pursuant to resolution numbered 4 above be and is hereby extended by the additional thereto of an amount representing the aggregate number of Shares repurchased by the Company under the authority granted pursuant to resolution numbered 5 above, provided that such amount shall not exceed 10% of the aggregate number of shares of the Company in issue as at the date of passing the resolution.”
|
| 2023-02-21 |
股东大会：
将于2023-04-04召开股东大会
|
| 2022-12-01 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2022-03-03 |
股东大会：
将于2022-04-08召开股东大会
会议内容 ▼▲
- 1.in connection with the proposed listing on the Hong Kong Stock Exchange, to amend and restate the third amended and restated memorandum and articles of association of the Company currently in effect by deletion in their entirety and substitution in their place of the Company’s fourth amended and restated memorandum and articles of association, which is conditional upon and will be effective immediately prior to the completion of the Company’s listing on the Hong Kong Stock Exchange (the “Listing”);
2.to approve the granting of a general mandate to the Directors to allot, issue or deal with additional shares of the Company not exceeding 20% of the total number of issued shares immediately following the Listing, and which is conditional upon the Listing (the “Issuance Mandate”);
3.to approve the granting of a general mandate to the Directors to exercise powers of the Company to repurchase shares of the Company representing up to 10% of the total number of issued shares immediately following the Listing, and which is conditional upon the Listing (the “Repurchase Mandate”);
4.subject to an approval of the Issuance Mandate and the Repurchase Mandate and conditional upon the Listing, to approve an extension to the Issuance Mandate, such that the number of shares of the Company purchased under the Repurchase Mandate will also be added to extend the Issuance Mandate, provided that such additional amount shall not exceed 10% of the number of issued shares of the Company immediately following the Listing;
5.to authorize each of the directors of the Company or Maples Corporate Services Limited to take related actions that might be necessary to effect the foregoing resolutions.
|
| 2021-11-18 |
股东大会：
将于2021-12-20召开股东大会
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-11-06 |
股东大会：
将于2020-12-10召开股东大会
|